XINSITOL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

XINSITOL Trademark

Serial Number: 79374677 • Registration: 7574726

XINSITOL is a trademark filed by Zhuhai Trinomab Pharmaceutical Co., Ltd. on May 30, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Zhuhai Trinomab Pharmaceutical Co., Ltd. (9 trademarks)

Rm.110, 1/F., Plant Building 6,

Entity Type: 99

Trademark Details

Filing Date

May 30, 2023

Registration Date

November 26, 2024

Published for Opposition

September 24, 2024

Goods & Services

Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of kidney disease; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; Biological preparations for medical purposes, namely, biological reagents for medical purposes; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; Biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; Biological preparations for medical purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; Vaccines; Antiallergic medicines for human purposes; Medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; Diagnostic preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Protein supplements for animals; Absorbent wadding for medical purposes

Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; Marketing services; Commercial administration of the licensing of the goods and services of others; Presentation of goods on communication media, for retail purposes, namely, providing television home shopping services in the field of general consumer merchandise; Advertising services

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 24, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 24, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 24, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 24, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 9, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 22, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 22, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 26, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 4, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 18, 2024 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 21, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 16, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 26, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 5, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 4, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2024 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 22, 2023 ADCH
APPLICATION FILING RECEIPT MAILED
Jul 25, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 21, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 20, 2023 REPR